NCT05285618

Brief Summary

This Basic Experimental Studies Involving Humans (BESH) study investigates phosphene perception and performance factors in blind participants implanted with the Argus II retinal prosthesis system. Using paired-electrode stimulation, we analyze how phosphene shape and number are influenced by neuroanatomical factors, stimulus parameters, and spatial offsets. Additionally, we examine the causes of high current thresholds and limited spatial resolution, which impede pattern vision in Argus II devices. This research aims to provide insights for optimizing stimulation strategies and improving retinal prosthesis design.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 11, 2022

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

February 4, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 17, 2022

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2023

Completed
1.3 years until next milestone

Results Posted

Study results publicly available

January 1, 2025

Completed
Last Updated

January 1, 2025

Status Verified

December 1, 2024

Enrollment Period

1.6 years

First QC Date

February 4, 2022

Results QC Date

November 27, 2024

Last Update Submit

December 22, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Phosphenes Perceived

    Number of phosphenes perceived in response to paired-electrode stimulation across 5 spatial distances and 7 temporal interpulse delays. Phosphenes are brief sensations of light or visual flashes that occur in the absence of an external light source. A response is counted as a phosphene if the participant reports any visual sensation consistent with a flash of light.

    during single-session testing

Study Arms (1)

Argus II users

EXPERIMENTAL

This Basic Experimental Studies Involving Humans (BESH) study investigates phosphene perception and performance factors in blind participants implanted with the Argus II retinal prosthesis system. Using paired-electrode stimulation, we analyze how phosphene shape and number are influenced by neuroanatomical factors, stimulus parameters, and spatial offsets. Additionally, we examine the causes of high current thresholds and limited spatial resolution, which impede pattern vision in Argus II devices. This research aims to provide insights for optimizing stimulation strategies and improving retinal prosthesis design.

Device: Argus II

Interventions

Argus IIDEVICE

Participants used the Argus II retinal prosthesis system in both experiments to perform visual perception tasks.

Argus II users

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject must be at least 25 years of age;
  • Subject has been implanted with the Argus II system;
  • Subject's eye has healed from surgery and the surgeon has cleared the subject for programming;
  • Subject has the cognitive and communication ability to participate in the study (i.e., follow spoken directions, perform tests, and give feedback);
  • Subject is willing to conduct psychophysics testing up to 4-6 hours per day of testing on 3-5 consecutive days;
  • Subject is capable of understanding patient information materials and giving written informed consent;
  • Subject is able to walk unassisted.

You may not qualify if:

  • Subject is unwilling or unable to travel to testing facility for at least 3 days of testing within a one-week timeframe;
  • Sighted controls: Subject has a history of motion sickness or flicker vertigo
  • Subject does not speak English;
  • Subject has language or hearing impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of California, Santa Barbara

Santa Barbara, California, 93106, United States

Location

Johns Hopkins University

Baltimore, Maryland, 21287, United States

Location

University of Michigan, Ann Arbor

Ann Arbor, Michigan, 48109, United States

Location

Related Publications (2)

  • Yucel EI, Sadeghi R, Kartha A, Montezuma SR, Dagnelie G, Rokem A, Boynton GM, Fine I, Beyeler M. Factors affecting two-point discrimination in Argus II patients. Front Neurosci. 2022 Aug 24;16:901337. doi: 10.3389/fnins.2022.901337. eCollection 2022.

  • Hou Y, Nanduri D, Granley J, Weiland JD, Beyeler M. Axonal stimulation affects the linear summation of single-point perception in three Argus II users. J Neural Eng. 2024 Apr 8;21(2):026031. doi: 10.1088/1741-2552/ad31c4.

MeSH Terms

Conditions

Retinitis Pigmentosa

Condition Hierarchy (Ancestors)

Eye Diseases, HereditaryEye DiseasesRetinal DystrophiesRetinal DegenerationRetinal DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Results Point of Contact

Title
Michael Beyeler
Organization
University of California, Santa Barbara

Study Officials

  • Michael Beyeler, PhD

    University of California, Santa Barbara

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 4, 2022

First Posted

March 17, 2022

Study Start

January 11, 2022

Primary Completion

August 31, 2023

Study Completion

August 31, 2023

Last Updated

January 1, 2025

Results First Posted

January 1, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Deidentified data will be available from the investigative team, following initial publication of the results

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Spring 2023 onward
Access Criteria
Any researchers with a legitimate reason for wishing to re-analyze the data or compare them to study data collected in similar experiments

Locations